PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 115 filers reported holding PULMONX CORP in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $311,667 | +73.2% | 30,171 | +119.8% | 0.00% | – |
| Q2 2023 | $179,947 | -90.8% | 13,726 | -92.1% | 0.00% | -100.0% |
| Q1 2023 | $1,954,476 | +1774.4% | 174,819 | +1313.4% | 0.00% | – |
| Q4 2022 | $104,271 | -54.7% | 12,369 | -10.5% | 0.00% | – |
| Q3 2022 | $230,000 | +29.2% | 13,824 | +14.8% | 0.00% | – |
| Q2 2022 | $178,000 | -32.1% | 12,039 | +13.7% | 0.00% | – |
| Q1 2022 | $262,000 | -24.3% | 10,592 | -1.9% | 0.00% | – |
| Q4 2021 | $346,000 | -18.8% | 10,793 | -8.7% | 0.00% | – |
| Q3 2021 | $426,000 | -94.4% | 11,815 | -93.2% | 0.00% | -100.0% |
| Q2 2021 | $7,612,000 | -11.2% | 172,524 | -7.9% | 0.00% | 0.0% |
| Q1 2021 | $8,571,000 | -50.5% | 187,395 | -25.3% | 0.00% | -60.0% |
| Q4 2020 | $17,309,000 | – | 250,773 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |